FALCO HOLDINGS Co., Ltd. (4671.T)
JPY 2282.0
(-0.26%)
JPY 2282.0
(-0.26%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.13 Billion JPY | -28.32% |
| 2022 | 4.11 Billion JPY | -35.64% |
| 2021 | 6.46 Billion JPY | 81.62% |
| 2020 | 3.56 Billion JPY | 193.1% |
| 2019 | 1.77 Billion JPY | -46.76% |
| 2018 | 2.16 Billion JPY | -26.85% |
| 2017 | 3.08 Billion JPY | 4.13% |
| 2016 | 3.02 Billion JPY | -0.41% |
| 2015 | 3.02 Billion JPY | 8.86% |
| 2014 | 2.74 Billion JPY | 6.27% |
| 2013 | 2.63 Billion JPY | -33.6% |
| 2012 | 4.14 Billion JPY | -3.61% |
| 2011 | 4.12 Billion JPY | -2.58% |
| 2010 | 4.2 Billion JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 2.49 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 625.5 Million JPY | 7.37% |
| 2023 Q4 | 957 Million JPY | 14.2% |
| 2023 Q3 | 838 Million JPY | 29.32% |
| 2023 Q2 | 648 Million JPY | 113.16% |
| 2023 Q1 | 304 Million JPY | -51.05% |
| 2023 FY | - JPY | -28.32% |
| 2022 FY | - JPY | -35.64% |
| 2022 Q3 | 820 Million JPY | -26.26% |
| 2022 Q1 | 774 Million JPY | -55.47% |
| 2022 Q2 | 1.11 Billion JPY | 43.67% |
| 2022 Q4 | 621 Million JPY | -24.27% |
| 2021 Q3 | 736 Million JPY | -63.46% |
| 2021 Q1 | 1.34 Billion JPY | 16.31% |
| 2021 FY | - JPY | 81.62% |
| 2021 Q2 | 2.01 Billion JPY | 50.19% |
| 2021 Q4 | 1.73 Billion JPY | 136.14% |
| 2020 Q3 | 948 Million JPY | 13.53% |
| 2020 Q2 | 835 Million JPY | 649.34% |
| 2020 Q4 | 1.15 Billion JPY | 21.62% |
| 2020 FY | - JPY | 193.1% |
| 2020 Q1 | -152 Million JPY | -146.2% |
| 2019 Q3 | 40 Million JPY | -90.07% |
| 2019 Q1 | 503 Million JPY | 40.9% |
| 2019 FY | - JPY | -46.76% |
| 2019 Q4 | 329 Million JPY | 722.5% |
| 2019 Q2 | 403 Million JPY | -19.88% |
| 2018 Q3 | 768 Million JPY | 9.56% |
| 2018 FY | - JPY | -26.85% |
| 2018 Q4 | 357 Million JPY | -53.52% |
| 2018 Q2 | 701 Million JPY | 23.2% |
| 2018 Q1 | 569 Million JPY | -31.86% |
| 2017 Q4 | 835 Million JPY | 9.72% |
| 2017 Q1 | 800 Million JPY | -0.25% |
| 2017 Q3 | 761 Million JPY | -13.33% |
| 2017 Q2 | 878 Million JPY | 9.75% |
| 2017 FY | - JPY | 4.13% |
| 2016 Q4 | 802 Million JPY | -5.31% |
| 2016 Q2 | 888 Million JPY | 46.29% |
| 2016 Q3 | 847 Million JPY | -4.62% |
| 2016 Q1 | 607 Million JPY | -25.61% |
| 2016 FY | - JPY | -0.41% |
| 2015 Q1 | 790 Million JPY | 13.67% |
| 2015 Q3 | 892 Million JPY | 35.36% |
| 2015 Q2 | 659 Million JPY | -16.58% |
| 2015 FY | - JPY | 8.86% |
| 2015 Q4 | 816 Million JPY | -8.52% |
| 2014 Q3 | 782 Million JPY | -5.1% |
| 2014 Q4 | 695 Million JPY | -11.13% |
| 2014 FY | - JPY | 6.27% |
| 2014 Q1 | 599 Million JPY | 279.11% |
| 2014 Q2 | 824 Million JPY | 37.56% |
| 2013 Q2 | 836 Million JPY | -23.58% |
| 2013 FY | - JPY | -33.6% |
| 2013 Q1 | 1.09 Billion JPY | 0.64% |
| 2013 Q3 | 641 Million JPY | -23.33% |
| 2013 Q4 | 158 Million JPY | -75.35% |
| 2012 Q3 | 1.07 Billion JPY | 14.96% |
| 2012 FY | - JPY | -3.61% |
| 2012 Q2 | 936 Million JPY | -7.42% |
| 2012 Q1 | 1.01 Billion JPY | 46.1% |
| 2012 Q4 | 1.08 Billion JPY | 1.02% |
| 2011 FY | - JPY | -2.58% |
| 2011 Q2 | 1.09 Billion JPY | -5.46% |
| 2011 Q4 | 692 Million JPY | -47.85% |
| 2011 Q3 | 1.32 Billion JPY | 21.63% |
| 2011 Q1 | 1.15 Billion JPY | 2.4% |
| 2010 FY | - JPY | 0.0% |
| 2010 Q3 | 1.22 Billion JPY | 6.82% |
| 2010 Q2 | 1.14 Billion JPY | 29.45% |
| 2010 Q1 | 883 Million JPY | 0.0% |
| 2010 Q4 | 1.12 Billion JPY | -7.7% |
| 2009 Q3 | 791 Million JPY | 0.0% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q4 | - JPY | -100.0% |
| 2008 Q3 | 915 Million JPY | 0.0% |
| 2008 Q4 | 639 Million JPY | -30.16% |
| 2008 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 8.98 Billion JPY | 65.127% |
| DNA Chip Research Inc. | -217 Million JPY | 1543.318% |
| Cosmo Bio Company,Limited | 669 Million JPY | -368.161% |
| H.U. Group Holdings, Inc. | 13.64 Billion JPY | 77.05% |
| BML, Inc. | 16.41 Billion JPY | 80.925% |
| Human Metabolome Technologies, Inc. | 306.48 Million JPY | -921.913% |
| Precision System Science Co., Ltd. | -661.75 Million JPY | 573.291% |